Edward Hook, MD

Edward Hook, MD, emeritus professor of Medicine, University of Alabama at Birmingham.

Articles by Edward Hook, MD

Oral zoliflodacin offers new option for gonorrhea treatment, says Edward Hook, MD

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

December 12th 2025

Edward Hook, MD, discusses the FDA approval of oral zoliflodacin and its role in expanding treatment options for uncomplicated gonorrhea amid rising resistance.

Edward Hook, MD

Articles by Edward Hook, MD

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

Latest Updated Articles

Trending on Contemporary OB/GYN

DARE to PLAY sildenafil cream becomes commercially available for women in select states

George L. Maxwell, MD, discusses phase 3 SUNFLOWER trial to evaluate Mirena for nonatypical endometrial hyperplasia

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

FDA approves gepotidacin (Blujepa) oral therapy for uncomplicated urogenital gonorrhea

Zoliflodacin demonstrated non-inferiority in adults and adolescents with gonorrhea